DrugPatentWatch Database Preview
Romiplostim - Biologic Drug Details
Summary for romiplostim
| Tradenames: | 1 |
| Patents: | 18 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for romiplostim
| Mechanism of Action | Thrombopoietin Receptor Agonists |
| Physiological Effect | Increased Megakaryocyte Maturation Increased Platelet Production |
US Patents for romiplostim
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Sign Up | University of the Sciences of Philadelphia (Philadelphia, PA) | ➤ Sign Up | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Sign Up | ➤ Sign Up | RX | search | ||
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Sign Up | Amgen Inc. (Thousand Oaks, CA) | ➤ Sign Up | RX | company | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | ➤ Sign Up | Amgen Inc. (Thousand Oaks, CA) | ➤ Sign Up | RX | company | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for romiplostim
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014100779 | ➤ Sign Up |
| China | 1721447 | ➤ Sign Up |
| European Patent Office | 2934555 | ➤ Sign Up |
| China | 105101979 | ➤ Sign Up |
| Eurasian Patent Organization | 200100464 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for romiplostim
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 6 | Finland | ➤ Sign Up | |
| /2009 | Austria | ➤ Sign Up | PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204 |
| 2009 00025 | Denmark | ➤ Sign Up | |
| 1124961/01 | Switzerland | ➤ Sign Up | FORMER REPRESENTATIVE: BOHEST AG, CH |
| C/GB09/035 | United Kingdom | ➤ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB09/035 GRANTED TO KIRIN-AMGEN INC. IN RESPECT OF THE PRODUCT ROMIPLOSTIM, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6361 DATED 20/04/2011 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 05/02/2024. |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
